(Q33518324)

English

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

diabetic retinopathy

1 reference

based on heuristic

inferred from title

Diabetic Retinopathy Clinical Research Network

8

object named as

Diabetic Retinopathy Clinical Research Network

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Adam R Glassman

7

object named as

Adam R Glassman

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Neil M. Bressler

4

object named as

Neil M Bressler

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Abdhish R Bhavsar

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Joseph M Googe

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Cynthia R Stockdale

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Alexander J Brucker

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Michael J Elman

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

JAMA Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

127

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1581-1583

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Evolving guidelines for intravitreous injections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Intravitreal triamcinolone for refractory diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Prophylaxis of Endophthalmitis with Topical Povidone-iodine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

21 June 2018

Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Reducing the risk of endophthalmitis following intravitreal injections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874253

31 October 2018

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/20008710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/20008710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20008710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/20008710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/ARCHOPHTHALMOL.2009.304

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33518324&oldid=2035021236"